Medtronic's MiniMed Group filed for an initial public offering in the United States on Friday, as the medical device maker ...

And the market for insulin has changed fast. Since 2023, drug companies have cut costs voluntarily, spurred by government ...

Senseonics earns a buy with Eversense 365 driving growth, Q3 revenue up 90% YoY, gross margin expansion, and Ascensia ...

(Bloomberg) --MiniMed Group Inc., a diabetes management firm that will be separated from health care giant Medtronic Plc, filed for an initial public offering, disclosing growing revenue and a ...

Medtronic initially secured FDA clearance for the MiniMed 780G pump for people with Type 1 diabetes in early 2023. This past ...

The insulin storage system market offers key opportunities in enhancing storage infrastructure for compliance and reliability ...

The expansion follows a 35% year-over-year increase in North American orders during 2024, driven by growing demand from ...

The global drug-device combination products market is projected to experience a compound annual growth rate (CAGR) of ...

Our cells follow 24-hour circadian rhythms that regulate our blood sugar levels and are heavily influenced by light exposure.

Medtronic plc (MDT) filed a registration statement with the U.S. Securities and Exchange Commission for an initial public offering of its diabetes business, which will operate under the name MiniMed, ...

Detailed price information for Beta Bionics Inc (BBNX-Q) from The Globe and Mail including charting and trades.

MiniMed intends to apply to have its common stock listed on the Nasdaq Global Select Market under the symbol MMED. The number of shares to be offered and the price range for the offering have not yet ...